Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
KIDS 
Orthopediatrics Corp (KIDS)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/28/2025: KIDS (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
7 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $33.86
1 Year Target Price $33.86
| 3 | Strong Buy |
| 3 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -49.09% | Avg. Invested days 26 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/28/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 535.57M USD | Price to earnings Ratio - | 1Y Target Price 33.86 |
Price to earnings Ratio - | 1Y Target Price 33.86 | ||
Volume (30-day avg) 7 | Beta 1.12 | 52 Weeks Range 16.59 - 33.14 | Updated Date 08/29/2025 |
52 Weeks Range 16.59 - 33.14 | Updated Date 08/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.8 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-08-05 | When - | Estimate -0.29 | Actual -0.11 |
Profitability
Profit Margin -18.92% | Operating Margin (TTM) -12.58% |
Management Effectiveness
Return on Assets (TTM) -4.38% | Return on Equity (TTM) -11.49% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 564597026 | Price to Sales(TTM) 2.43 |
Enterprise Value 564597026 | Price to Sales(TTM) 2.43 | ||
Enterprise Value to Revenue 2.56 | Enterprise Value to EBITDA -79.86 | Shares Outstanding 25073600 | Shares Floating 16872278 |
Shares Outstanding 25073600 | Shares Floating 16872278 | ||
Percent Insiders 32.71 | Percent Institutions 70.87 |
Upturn AI SWOT
Orthopediatrics Corp
Company Overview
History and Background
Orthopediatrics Corp. was founded in 2006 and is dedicated to developing, manufacturing, and distributing orthopedic implants and instruments exclusively for pediatric patients. They focus on addressing the unmet needs of children with orthopedic conditions through innovative solutions.
Core Business Areas
- Trauma and Deformity Correction: This segment focuses on products used to treat fractures, limb length discrepancies, and spinal deformities in children.
- Sports Medicine and Soft Tissue: This segment includes products for treating sports-related injuries and soft tissue conditions common in pediatric patients.
- Specialty Products: This segment includes specialized implants and instruments for less common pediatric orthopedic conditions.
Leadership and Structure
The company is led by a management team with experience in the orthopedic industry. The organizational structure includes departments for research and development, manufacturing, sales and marketing, and finance.
Top Products and Market Share
Key Offerings
- PediLoc Plating System: A plating system designed for pediatric fractures. Market share data is proprietary, but it is a significant contributor to Orthopediatrics' revenue. Competitors include DePuy Synthes (JNJ) and Stryker (SYK).
- Response Scoliosis System: A scoliosis correction system designed specifically for children. Market share data is proprietary. Competitors include Medtronic (MDT) and NuVasive (NUVA).
- Cannulated Blade System: A hip preservation system designed specifically for children. Market share data is proprietary. Competitors include Smith & Nephew (SNN) and Zimmer Biomet (ZBH).
Market Dynamics
Industry Overview
The pediatric orthopedic market is growing due to increasing awareness of pediatric orthopedic conditions and advancements in medical technology. The market is characterized by specialized needs and regulatory requirements.
Positioning
Orthopediatrics Corp. is a leader in the pediatric orthopedic market, focusing exclusively on pediatric patients. This specialization gives them a competitive advantage over larger orthopedic companies with broader portfolios.
Total Addressable Market (TAM)
The total addressable market for pediatric orthopedics is estimated to be several billion dollars globally. Orthopediatrics is well-positioned to capture a significant share of this market through its specialized product offerings and focused strategy.
Upturn SWOT Analysis
Strengths
- Specialized focus on pediatric orthopedics
- Innovative product development
- Strong relationships with pediatric orthopedic surgeons
- Dedicated sales force
Weaknesses
- Smaller size compared to larger orthopedic companies
- Limited resources for marketing and distribution
- Dependence on a niche market
Opportunities
- Expanding product portfolio
- Geographic expansion
- Increasing awareness of pediatric orthopedic conditions
- Strategic partnerships and acquisitions
Threats
- Competition from larger orthopedic companies
- Regulatory changes
- Pricing pressures
- Economic downturns
Competitors and Market Share
Key Competitors
- JNJ
- MDT
- SYK
- SNN
- ZBH
- NUVA
Competitive Landscape
Orthopediatrics Corp. differentiates itself through its exclusive focus on pediatric orthopedics. While larger competitors have broader portfolios, Orthopediatrics offers specialized products and expertise tailored to the unique needs of children.
Major Acquisitions
Response Orthopedics
- Year: 2019
- Acquisition Price (USD millions): 25
- Strategic Rationale: Expanded the company's scoliosis product line.
Growth Trajectory and Initiatives
Historical Growth: Discuss Orthopediatrics Corp's growth trends over the past years.
Future Projections: Provide projections for Orthopediatrics Corp's future growth based on analyst estimates.
Recent Initiatives: Highlight recent strategic initiatives undertaken by Orthopediatrics Corp.
Summary
Orthopediatrics Corp. is a specialized player in the pediatric orthopedic market with a focused strategy and innovative product offerings. Its dedicated approach has allowed it to establish a strong position, but it faces challenges from larger competitors and the need to scale its operations. Growth opportunities lie in expanding its product line, geographic reach, and strategic partnerships. The company needs to be aware of regulatory changes and pricing pressures.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Market research reports
- Analyst estimates
Disclaimers:
This analysis is for informational purposes only and should not be considered investment advice. Market share estimates are approximate and based on available data.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Orthopediatrics Corp
Exchange NASDAQ | Headquaters Warsaw, IN, United States | ||
IPO Launch date 2017-10-12 | President, CEO & Director Mr. David R. Bailey | ||
Sector Healthcare | Industry Medical Devices | Full time employees 562 | Website https://www.orthopediatrics.com |
Full time employees 562 | Website https://www.orthopediatrics.com | ||
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti, and Boston Brace 3D. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.